Lab Reagents
Antibody Elisa Laboratories manufactures the bispecific antibody elisa reagents distributed by Genprice. The Bispecific Antibody Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Bispecific products are available in stock. Specificity: Bispecific Category: Antibody Group: Elisa
Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-066-100ug | Creative Biolabs | 100μg | EUR 3560 |
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy. |
Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-066-50ug | Creative Biolabs | 50μg | EUR 2039 |
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy. |
Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv) |
|||
BSFV-072-100ug | Creative Biolabs | 100μg | EUR 3560 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy. |
Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv) |
|||
BSFV-072-50ug | Creative Biolabs | 50μg | EUR 2039 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy. |
Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-077-100ug | Creative Biolabs | 100μg | EUR 3560 |
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-077-50ug | Creative Biolabs | 50μg | EUR 2039 |
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-079-100ug | Creative Biolabs | 100μg | EUR 3560 |
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-079-50ug | Creative Biolabs | 50μg | EUR 2039 |
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
|||
BSFV-102-100ug | Creative Biolabs | 100μg | EUR 3560 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
|||
BSFV-102-50ug | Creative Biolabs | 50μg | EUR 2039 |
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
|||
BSFV-162-100ug | Creative Biolabs | 100μg | EUR 3794 |
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
|||
BSFV-162-50ug | Creative Biolabs | 50μg | EUR 2156 |
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-c001-100ug | Creative Biolabs | 100μg | EUR 3794 |
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
BSFV-c001-50ug | Creative Biolabs | 50μg | EUR 2156 |
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
Recombinant Anti-CD3 x Anti-EPCAM Bispecific Antibody (Triple Body) |
|||
TRIB-079 | Creative Biolabs | 200μg | Ask for price |
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD3 antibody are both extended with the scFv fragment from an anti-EPCAM antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body) |
|||
TRIB-356-100ug | Creative Biolabs | 100μg | EUR 4028 |
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy. |
Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body) |
|||
TRIB-356-50ug | Creative Biolabs | 50μg | EUR 2507 |
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy. |